
Research
Combination of three immune-targeting drugs offers new hope for skin cancer patients
New triple immunotherapy could help melanoma patients who fail standard treatments, Moffitt Cancer Center study finds.
Joshua Shavit

New triple immunotherapy could help melanoma patients who fail standard treatments, Moffitt Cancer Center study finds.
Joshua Shavit